ArcticZymes Technologies ASA Stock

Equities

AZT

NO0010014632

Biotechnology & Medical Research

Real-time Oslo Bors 09:03:23 2024-06-03 am EDT 5-day change 1st Jan Change
26.4 NOK +3.12% Intraday chart for ArcticZymes Technologies ASA +3.12% -37.14%
Sales 2024 * 131M 12.48M Sales 2025 * 163M 15.58M Capitalization 1.3B 124M
Net income 2024 * 23M 2.19M Net income 2025 * 42M 4M EV / Sales 2024 * 8.52 x
Net cash position 2024 * 186M 17.73M Net cash position 2025 * 192M 18.29M EV / Sales 2025 * 6.79 x
P/E ratio 2024 *
57 x
P/E ratio 2025 *
31 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 70.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.22%
1 week-1.35%
1 month-0.97%
3 months-15.51%
6 months-35.27%
Current year-39.05%
More quotes
1 week
22.90
Extreme 22.9
26.45
1 month
22.00
Extreme 22
27.00
Current year
22.00
Extreme 22
43.20
1 year
22.00
Extreme 22
47.50
3 years
22.00
Extreme 22
109.00
5 years
3.52
Extreme 3.52
114.40
10 years
3.50
Extreme 3.5
114.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-09-17
Director of Finance/CFO 49 14-09-30
Chief Tech/Sci/R&D Officer - 22-11-30
Members of the board TitleAgeSince
Chief Tech/Sci/R&D Officer 52 99-12-31
Chief Operating Officer 56 -
Director/Board Member - -
More insiders
Date Price Change Volume
24-06-03 26.4 +3.12% 62 366
24-05-31 25.6 +6.22% 778,532
24-05-30 24.1 -1.03% 137,651
24-05-29 24.35 -0.61% 273,565
24-05-28 24.5 -4.30% 132,741

Real-time Oslo Bors, May 31, 2024 at 10:45 am EDT

More quotes
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
25.6 NOK
Average target price
27.5 NOK
Spread / Average Target
+7.42%
Consensus